A Meta-analysis of video-assisted thoracic segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer

郑鑫林; 夏学阳; 张金周

doi:10.19401/j.cnki.1007-3639.2016.10.008

您当前的位置：

首页 >

文章列表页 >

A Meta-analysis of video-assisted thoracic segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer

更新时间：2025-12-31

- A Meta-analysis of video-assisted thoracic segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer
- China Oncology Vol. 26, Issue 10, Pages: 854-860(2016)
- 作者机构：
  
  兰州大学第二医院普胸外科,甘肃,兰州,730030
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2016.10.008
  CLC：
- Published Online：17 November 2016，
  
  Published：17 November 2016
- 稿件说明：
移动端阅览
郑鑫林,夏学阳,张金周,等. 胸腔镜下肺段切除与肺叶切除治疗临床Ⅰ期非小细胞肺癌疗效对比的Meta分析[J]. 中国癌症杂志, 2016, 26(10): 854-860.

郑鑫林, 夏学阳, 张金周. A Meta-analysis of video-assisted thoracic segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer[J]. China Oncology, 2016, 26(10): 854-860.
郑鑫林,夏学阳,张金周,等. 胸腔镜下肺段切除与肺叶切除治疗临床Ⅰ期非小细胞肺癌疗效对比的Meta分析[J]. 中国癌症杂志, 2016, 26(10): 854-860. DOI： 10.19401/j.cnki.1007-3639.2016.10.008.

郑鑫林, 夏学阳, 张金周. A Meta-analysis of video-assisted thoracic segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer[J]. China Oncology, 2016, 26(10): 854-860. DOI： 10.19401/j.cnki.1007-3639.2016.10.008.

摘要

背景与目的：对于临床Ⅰ期非小细胞肺癌(non-small cell lung cancer，NSCLC)，胸腔镜下肺段切除因其对患者损伤更小而越来越受到胸外科医师的重视，但是腔镜下肺叶切除术仍被认为是标准的治疗方式。因此，系统评价胸腔镜下肺段切除与肺叶切除治疗临床Ⅰ期NSCLC的临床疗效，以期为临床决策提供借鉴。方法：计算机检索PubMed、Web of Science、EMBASE、The Cochrane Library、CNKI、CBM、VIP和万方等数据库，检索时间截至2015年7月，收集胸腔镜下肺段切除与肺叶切除治疗临床Ⅰ期NSCLC的对比研究，由2名研究员分别对纳入的研究进行数据提取和质量评价，最后采用Cochrane协作网提供的Revman 5.3软件进行Meta分析。结果：共纳入11篇回顾性临床对照研究，共计1 677例患者。Meta分析结果显示，对于临床Ⅰ期NSCLC，胸腔镜下肺段切除与肺叶切除术后总体复发率(OR=0.77，95%CI：0.48~1.21，P=0.25)、5年生存率(OR=0.77，95%CI：0.52~1.14，P=0.19)和全身并发症(OR=0.76，95%CI：0.53~1.09，P=0.13)差异均无统计学意义，但胸腔镜下肺段切除可减少术中失血量[均数差(difference in means，MD)=-41.16，95%CI：-59.46~-22.86，P0.000 1]、缩短术后胸管引流时间(MD=-0.29，95%CI：-0.49~-0.09，P=0.005)和住院时间(MD=-0.74，95%CI：-1.44~-0.05，P=0.04)。结论：对于临床Ⅰ期NSCLC，胸腔镜下肺段切除和肺叶切除在术后总体复发率、全身并发症和5年生存率上效果相当，但是在术中失血量、术后胸管引流时间和住院时间方面胸腔镜下肺段切除效果更好，是一种可供选择的手术方式。

Abstract

Background and purpose: For stage Ⅰ non-small cell lung cancer (NSCLC)

video-assisted thoracic segmentectomy is given much attention to by thoracic surgeon because of the less tissue damages. However

video-assisted thoracic lobectomy is still considered as the standard treatment in the world. Therefore

this study was to evaluate the clinical effect after video-assisted thoracic segmentectomy and lobectomy in patients with stage Ⅰ NSCLC in order to provide reference for clinical application. Methods: The comparative studies on video-assisted thoracic segmentectomy and lobectomy treating stage I NSCLC were retrieved from PubMed

Web of Science

EMBASE

the Cochrane Library

CNKI

CBM

VIP

and Wanfang Data. All data were acquired until July 2015. Literature screening according to data extraction and quality assessment was completed by two reviewers independently. Meta-analysis was conducted by RevMan 5.3 software which was offered by Cochrane network. Results: A total of 11 articles involving 1 677 patients were finally included. The results of meta-analysis indicated that: for stage Ⅰ NSCLC

compared with video-assisted thoracic lobectomy

the effect of video-assisted thoracic segmentectomy was alike in total mortality (OR=0.77

95%CI: 0.48 to 1.21

P=0.25)

5-year mortality (OR=0.77

95%CI: 0.52 to 1.14

P=0.19) and systemic complications (OR=0.76

95%CI: 0.53 to 1.09

P=0.13)

but could reduce blood loss [difference in means (MD)=-41.16

95%CI: -59.46 to -22.86

P0.000 1]

chest tube duration (MD=-0.29

95%CI: -0.49 to -0.09

P=0.005) and the length of hospital stay (MD=-0.74

95%CI: -1.44 to -0.05

P=0.04). Conclusion: Compared with video-assisted thoracic lobectomy

video-assisted thoracic segmentectomy can significantly reduce blood loss

chest tube duration and length of hospital stay. However

the two kinds of operation methods achieved the same effects on the total mortality

5-year mortality and systemic complications. Thoracoscopic segmentectomy may be an alternative to thoracic lobectomy.

关键词

Keywords

references

Views

1430

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis

Microwave ablation versus hepatic resection in potentially resectable colorectal liver metastasis: a systematic review and meta-analysis

Survival impact of corticosteroid and immunosuppressant management strategies for immune-related adverse events in immune checkpoint inhibitor-treated patients: a systematic review and meta-analysis

Research on high-throughput detection of plasma cell-free DNA for targeted therapy-related genes screening and prognosis prediction in non-small cell lung cancer patients

Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications

Related Author

ZHENG Jinmei

WU Wanghui

ZHENG Jimei

LIU Ji

WU Fei

WANG Mingxuan

SU Qiang

Zesong MENG

Related Institution

Department of Oncology, Beijing Friendship Hospital Capital Medical University

Department of Pathology, School of Basic Medical Sciences of Fujian Medical University

Zhangzhou Changtai District Hospital

Department of Emergency, Beijing Friendship Hospital Capital Medical University

The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University

AI问答

⁰